Financhill
Back

Intra-Cellular Therapies Vs. Braze Industry Stock Comparison

Sell
21

ITCI
Intra-Cellular Therapies

Last Price:
74.65
Seasonality Move:
0.51%
Sell
23

BRZE
Braze

Last Price:
35.03
Seasonality Move:
-2.96%
Sell
21
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $75.11. The Score for ITCI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Braze (BRZE) is a Sell

Is Braze a Buy, Sell or Hold?

  • The current Braze [BRZE] share price is $35.60. The Score for BRZE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BRZE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $75.11
    The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

BRZE Stock Price Chart

What is Braze's stock price today?

  • The Braze share price today is $35.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRZE is experiencing slight buying pressure.

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 53.11 Buy
Chaikin Money Flow: -208488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.22 - 75.6) Buy
Bollinger Bands (100): (68.18 - 76.66) Buy

BRZE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.85 Sell
Relative Strength Index (14 RSI): 36.45 Sell
Chaikin Money Flow: 215605 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.76 - 45.1) Sell
Bollinger Bands (100): (36.81 - 42.95) Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.65 Buy
20-day SMA: 74.17 Buy
50-day SMA: 75.78 Sell
200-day SMA: 70.36 Buy
8-day EMA: 74.7 Buy
20-day EMA: 74.51 Buy
50-day EMA: 74.31 Buy
200-day EMA: 69.75 Buy

BRZE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.14 Buy
20-day SMA: 40.69 Sell
50-day SMA: 40.51 Sell
200-day SMA: 45.87 Sell
8-day EMA: 36.34 Sell
20-day EMA: 38.77 Sell
50-day EMA: 39.99 Sell
200-day EMA: 42.69 Sell

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.

Braze Earnings Growth & BRZE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.42 per share, and an increase next year of $0.33 per share.

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Braze Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):